Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simplification to Atazanavir/Ritonavir + Lamivudine in HIV with Osteopenia
NCT02652793Completed
- Start
- Nov 2015
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of atazanavir, ritonavir and lamivudine in human immunodeficiency virus infection (HIV). Started Nov 2015; status: completed.
02
Drugs
atazanavirritonavirlamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02652793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02652793.